Genetic mutations: Identifying mutations that may cause or contribute to cancer development. Genetic alterations: Detecting changes in genes linked to cancer risk, aiding in hereditary risk assessment. Cancer type identification: Helps accurately determine the type of cancer based on genetic characteristics. Guiding treatment options: Provides information on targeted or immunotherapies appropriate based on the tumor’s genetic makeup. Predicting treatment response: Helps understand how a patient might respond to different therapies based on specific genes.

Patients diagnosed with cancer: To identify genetic mutations that may influence treatment options and patient response. Individuals with a family history of cancer: To assess hereditary risk and guide preventive screenings. Patients with rare or atypical tumors: The test can help identify genes associated with these tumors. High-risk individuals: Such as those with known mutations like BRCA1 or BRCA2 linked to breast and ovarian cancer. Individuals seeking informed treatment decisions: To obtain precise information to guide suitable therapy choices.

Cancer diagnosis: Detection of any type of cancer after initial medical tests. Unexplained symptoms: Such as unexplained weight loss, persistent fatigue, or nonspecific pain. Changes in vital signs: Unusual alterations in laboratory test results. Strong family history: Multiple cases of cancer in the family, suggesting hereditary risk. Rare or atypical tumors: Tumors with unclear causes or those not responding to conventional treatment.

What is the purpose of a Comprehensive Cancer Panel? It aims to identify genetic changes associated with various types of cancer, helping guide treatment options. How is the test performed? A blood or tissue sample is taken and analyzed in a laboratory using advanced genetic techniques. Does the patient need to fast before the test? Generally, fasting is not required, but it is best to consult the doctor. What factors may affect the test results? Certain medications, previous treatments, or the overall health condition may influence the results. What do positive or negative results mean? Positive results indicate the presence of genetic mutations that may affect treatment, while negative results indicate no known genetic changes. How are the test results used? Results help doctors determine suitable targeted therapies and predict the patient’s response to treatment. Are there any risks in performing the test? Risks are minimal, usually limited to mild bruising or discomfort at the sample collection site.

Presence of genetic mutations or changes: indicates certain risks or potential impact on treatment. Absence of mutations: generally indicates no known genetic cancer risks.

Comprehensive Cancer Panel | Lahalak Platform

An advanced genetic screening to identify mutations linked to various cancers, providing proactive insights for precise preventive measures and empowering early tumor detection to safeguard your long-term health.

Prices starts from: 4614.72 SAR

Scientific name: Comprehensive Cancer Genetic Panel

Comprehensive cancer panel analysis (Comprehensive Cancer Panel) is an advanced genetic test designed to identify genetic changes and mutations associated with various types of cancer. This analysis relies on sophisticated techniques to examine tissue or blood samples, providing precise information about the genetic characteristics of tumors. The t...

Comprehensive Cancer Genetic Panel - Comprehensive Early Cancer Detection

Service type Advanced Genetic Screening

Duration 15-20 minutes

Fasting Fasting is not required

Prices Starting from 4614.72 SAR

Included Services

Comprehensive Cancer Panel Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Genetic mutations: Identifying mutations that may cause or contribute to cancer development.
Genetic alterations: Detecting changes in genes linked to cancer risk, aiding in hereditary risk assessment.
Cancer type identification: Helps accurately determine the type of cancer based on genetic characteristics.
Guiding treatment options: Provides information on targeted or immunotherapies appropriate based on the tumor’s genetic makeup.
Predicting treatment response: Helps understand how a patient might respond to different therapies based on specific genes.

Recommended groups

Patients diagnosed with cancer: To identify genetic mutations that may influence treatment options and patient response.
Individuals with a family history of cancer: To assess hereditary risk and guide preventive screenings.
Patients with rare or atypical tumors: The test can help identify genes associated with these tumors.
High-risk individuals: Such as those with known mutations like BRCA1 or BRCA2 linked to breast and ovarian cancer.
Individuals seeking informed treatment decisions: To obtain precise information to guide suitable therapy choices.

Symptoms indicative

Cancer diagnosis: Detection of any type of cancer after initial medical tests.
Unexplained symptoms: Such as unexplained weight loss, persistent fatigue, or nonspecific pain.
Changes in vital signs: Unusual alterations in laboratory test results.
Strong family history: Multiple cases of cancer in the family, suggesting hereditary risk.
Rare or atypical tumors: Tumors with unclear causes or those not responding to conventional treatment.

FAQs

What is the purpose of a Comprehensive Cancer Panel? It aims to identify genetic changes associated with various types of cancer, helping guide treatment options.
How is the test performed? A blood or tissue sample is taken and analyzed in a laboratory using advanced genetic techniques.
Does the patient need to fast before the test? Generally, fasting is not required, but it is best to consult the doctor.
What factors may affect the test results? Certain medications, previous treatments, or the overall health condition may influence the results.
What do positive or negative results mean? Positive results indicate the presence of genetic mutations that may affect treatment, while negative results indicate no known genetic changes.
How are the test results used? Results help doctors determine suitable targeted therapies and predict the patient’s response to treatment.

Normal Levels

Presence of genetic mutations or changes: indicates certain risks or potential impact on treatment.
Absence of mutations: generally indicates no known genetic cancer risks.

Conditions & Notices

The terms and conditions announced on the "Lahalak" medical platform apply.
There are no special conditions for the service other than those mentioned.

Comprehensive Cancer Panel | Lahalak Platform

Included Services

Medical Service Information

Purpose Test

Recommended groups

Symptoms indicative

FAQs

Normal Levels

Conditions & Notices

Medical services you might also like

Fatty Acid Disorders Profile

PML-RAR Alpha Genetic Test

Galactocerebrosidase Enzyme Test

Newborn Tyrosinemia Screening